Proven Results: Stroke Treatment Outcomes
“Advancing Stroke Care Excellence: Because Every Second Counts… and Every Patient Deserves Their Quality of Life Back”
When it comes to stroke, the deepest fear is not just about survival — it is the fear of facing permanent disability or never being able to live independently again. Every second that blood fails to reach the brain means another lost chance at being oneself.
The Center of Excellence in Neuroscience (CoE Neuro) at Bangkok Hospital Pattaya is transforming that fear into hope — through the internationally recognized ICHOM (International Consortium for Health Outcomes Measurement) standard, making it the first hospital in Thailand to receive this accreditation.
In 2025, the center saw continuous growth in patient volume, reflecting the trust of patients and referral networks, as well as its established role as a comprehensive neurological care center.
This growth reflects an increase not only in patient numbers but also in the complexity of care delivered.
Patient Statistics and Service Overview (2025)
0.0%
Overall Stroke Mortality Rate
World Stroke Organization (5%)
0%
Stroke Patients were able to Walk Home
Thailand’s national average of 26.1%
0.0%
Recurrent Stroke Rate
International Benchmark Ceiling of 1.5%
In 2025, the center recorded clear growth in both patient volume and disease complexity:
- Total patient volume: 26,232 patients served (up 7% from 2024), comprising 17,127 outpatients and 4,920 inpatients
- Patient breakdown: 55% international patients, 45% Thai patients
- Disease complexity: Case Mix Index (CMI) of 2.67 — above the general standard benchmark — and for the stroke patient group specifically, CMI reached 5.37
The stroke treatment outcomes at the CoE Neuroscience Center of Bangkok Hospital Pattaya demonstrate a high standard of care.
As the first hospital in Thailand to receive ICHOM accreditation, the center reflects a truly patient-centered approach to measuring treatment outcomes.
Mortality and Disability Rates Below Benchmark
- Overall stroke mortality rate: only 1.4% — significantly below the target of 7% and the World Stroke Organization’s reported rate of 5%
- Walking home at discharge: 51% of stroke patients were able to walk home — nearly double Thailand’s national average of 26.1%
- Recurrent stroke rate: controlled at 0.4% — well below the international benchmark ceiling of 1.5%
Stroke Treatment Outcomes Mechanical Thrombectomy (MT)
0-87%
Successful Vessel Recanalization Rate
International Organizations such as the AHA (75%) and the ESCAPE Trial (72%)
0%
Able to Return to Independent Daily Living
International Organizations such as the AHA (78%) and the ESCAPE Trial (53%)
0%
Door-to-Groin (Endovascular Catheterization)
Completed within 120 minutes in 89%
Mechanical Thrombectomy (MT) results stand out across multiple dimensions:
- Successful vessel recanalization rate (TICI grade 2B–3): achieved at 85–87%, surpassing the set target of 65%, and exceeding reports from international organizations such as the AHA (75%) and the ESCAPE trial (72%)
- Functional independence: among patients treated with MT, 81% were able to return to independent daily living — better than international outcomes including AHA (78%) and ESCAPE (53%)
Speed of Treatment — Stroke Fast Track
- Door-to-Needle (thrombolytic injection): achieved within 60 minutes in 64% of cases, with an elevated standard of within 45 minutes achieved in 45% of cases
- Door-to-Groin (endovascular catheterization): completed within 120 minutes in 89% of cases
Statistics of Intracerebral Hemorrhage (ICH) Care and Patient Experience and Satisfaction
0%
Mortality Rate of All ICH (Moderate to Severe and Severe)
Below the International Target of 25%
0.0%
HCAHPS Inpatient Satisfaction Score
Patient Experience
0%
Confidence and Likelihood to Recommend
Net Promoter Score (NPS)
Intracerebral Hemorrhage (ICH) Care
Even among patients classified as moderate-to-severe and severe — accounting for more than 80% of all ICH cases — the hospital maintained a mortality rate of just 11%, well below the international target of 25% and comparing favorably with leading ICH centers worldwide.
Patient Experience and Satisfaction
Satisfaction outcomes exceeded benchmarks at both network and international levels:
- HCAHPS inpatient satisfaction score: 98.36% — surpassing the US benchmark of 88%
- Net Promoter Score (NPS), measuring confidence and likelihood to recommend: 97.74–98.23 — clearly above the US international reference of 71%
In summary, stroke care outcomes here go beyond survival. The focus is on meaningful life — restoring genuine quality of life after treatment — with evidence-based results that match or exceed those of leading institutions worldwide.
Frequently Asked Questions on Stroke Treatment
The golden hour refers to the first 4.5 hours from the onset of symptoms — such as facial drooping, limb weakness, or slurred speech. If a patient arrives at the hospital and receives thrombolytic medication (rt-PA) within this window, the chances of recovery and the risk of paralysis are significantly improved.
Watch for the B.E.F.A.S.T. signs: B (Balance — sudden loss of balance), E (Eyes — sudden vision loss or double vision), F (Face — facial drooping or uneven smile), A (Arms — sudden weakness on one side), S (Speech — slurred speech or difficulty finding words), and T (Time — get to the hospital as fast as possible).
We offer comprehensive care from start to finish — including intravenous thrombolysis (rt-PA), Mechanical Thrombectomy for large vessel occlusion, brain surgery when indicated, and full physical rehabilitation therapy.
Recovery depends on the severity of the stroke and how quickly treatment is received. Based on our data, patients who receive timely treatment within 4.5 hours and undergo continuous rehabilitation have a very high chance of returning to near-normal daily life.